Related Experiment Video
Updated: Apr 17, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Hospitalization due to cancer among German seafarers
Marcus Oldenburg1, Volker Harth, Ulf Manuwald
1Institute for Occupational and Maritime Medicine, ZfAM, University Medical Center Hamburg-Eppendorf, Germany.
Objectives:
To evaluate the relative risk of cancer among male German seafarers employed on German vessels in respect of various shipboard ranks and types of vessel.
Methods:
The seafarers' cancer discharge diagnoses from hospital were compared with those discharge diagnoses from the German general population and expressed as a standardized hospitalization ratio (SHR).
Results:
The examined seafarers (on average 23,436 per year) showed a higher SHR for malignant neoplasms at all sites, in decreasing order for leukemia, non-Hodgkin lymphoma (NHL), respiratory cancer, and non-melanoma skin cancer. Seafarers employed on tankers showed a considerably elevated SHR for malignant neoplasms at all sites, which was mainly attributable to their high SHR for leukemia and respiratory cancer.
Conclusions:
Seafaring occupations pose an elevated risk of certain cancers. Further studies are required to evaluate to what extent occupational exposure to carcinogenic substances and lifestyle-related unhealthy behaviours contribute to the increased risk of cancer in seafarers.
Related Concept Videos
Cancer Survival Analysis
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
